New antibiotic approach may cut infections after pancreatic surgery

NCT ID NCT07531420

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looked at 117 patients who had pancreatic surgery to see if changing the antibiotic given before surgery could reduce infections. The researchers compared an older antibiotic (cephalosporin) with a newer one (piperacillin/tazobactam) based on local bacteria patterns. The goal was to find the best way to prevent surgical site infections while avoiding overuse of strong antibiotics.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
piperacillin/tazobactam (an antibiotic)
What this could lead to
If successful, this could help hospitals choose the best antibiotic to prevent infections after pancreatic surgery, reducing complications and the need for stronger antibiotics.
What could go wrong
This is a small, single-center study, so results may not apply to other hospitals. The infection risk depends on local bacteria, so the best antibiotic may vary by location.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANTIBIOTIC PROPHYLAXIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Surgical Wound Infection

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University Hospital of Nancy

    Nancy, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.